NASDAQ
CINGW

Cingulate Inc. Warrants

Biotechnology
Healthcare

Prices are adjusted according to historical splits.

Cingulate Inc. Warrants Stock Price

Vitals

Today's Low:
$0.088
Today's High:
$0.088
Open Price:
$0.088
52W Low:
$0.06
52W High:
$0.45
Prev. Close:
$0.1278
Volume:
0

Company Statistics

Market Cap.:
$0
Book Value:
0.277
Revenue TTM:
$0
Operating Margin TTM:
0%
Gross Profit TTM:
$0
Profit Margin:
0%
Return on Assets TTM:
0%
Return on Equity TTM:
0%

Company Profile

Cingulate Inc. Warrants had its IPO on 2021-12-08 under the ticker symbol CINGW.

The company operates in the Healthcare sector and Biotechnology industry. Cingulate Inc. Warrants has a staff strength of 13 employees.

Stock update

Shares of Cingulate Inc. Warrants opened at $0.09 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.09 - $0.09, and closed at $0.09.

This is a -31.14% slip from the previous day's closing price.

A total volume of 0 shares were traded at the close of the day’s session.

In the last one week, shares of Cingulate Inc. Warrants have slipped by -20%.

Cingulate Inc. Warrants's Key Ratios

Cingulate Inc. Warrants has a market cap of $0, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months Cingulate Inc. Warrants’s revenue was $0 with a gross profit of $0 and an EBITDA of $-18477114. The EBITDA ratio measures Cingulate Inc. Warrants's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Cingulate Inc. Warrants’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q1, Cingulate Inc. Warrants’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Cingulate Inc. Warrants’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $-1.732 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Cingulate Inc. Warrants’s profitability.

Cingulate Inc. Warrants stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

Cingulate Inc. Warrants stock pays annual dividends of $ per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$7.16 million
Total Liabilities
$6.66 million
Operating Cash Flow
$0
Capital Expenditure
$37135
Dividend Payout Ratio
0%

Cingulate Inc. Warrants ended 2024 with $7.16 million in total assets and $0 in total liabilities. Its intangible assets were valued at $7.16 million while shareholder equity stood at $81614.00.

Cingulate Inc. Warrants ended 2024 with $0 in deferred long-term liabilities, $6.66 million in other current liabilities, 1131.00 in common stock, $-73413383.00 in retained earnings and $0 in goodwill. Its cash balance stood at $1.74 million and cash and short-term investments were $1.74 million. The company’s total short-term debt was $5,360,326 while long-term debt stood at $0.

Cingulate Inc. Warrants’s total current assets stands at $3.75 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $31953.00 compared to accounts payable of $599033.00 and inventory worth $0.

In 2024, Cingulate Inc. Warrants's operating cash flow was $0 while its capital expenditure stood at $37135.

Comparatively, Cingulate Inc. Warrants paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$0.09
52-Week High
$0.45
52-Week Low
$0.06
Analyst Target Price
$

Cingulate Inc. Warrants stock is currently trading at $0.09 per share. It touched a 52-week high of $0.45 and a 52-week low of $0.45. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.15 and 200-day moving average was $0.2 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Cingulate Inc. Warrants

The stock symbol (also called stock or share ticker) of Cingulate Inc. Warrants is CINGW

The IPO of Cingulate Inc. Warrants took place on 2021-12-08

Similar Industry Stocks (Biotechnology)

Last Price
Chg
Chg%
Lupin Limited (500257)
$1138.4
10.5
+0.93%
$941.75
-53.4
-5.37%
$2.88
0.1
+3.73%
$0.51
0.05
+11.11%
$347.2
3.68
+1.07%
$686.05
-27.6
-3.87%
$103.9
-9.25
-8.18%
$37.54
-1.08
-2.8%
$14.51
-0.01
-0.07%
CSL Finance Limited (CSLFINANCE)
$296.6
-16.75
-5.35%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of central nervous system and neurobiological disorders. The company’s lead product candidates are CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine) for the treatment of attention deficit/hyperactivity disorders. It also focuses on developing CTx-2103 for the treatment of anxiety disorders. The company was founded in 2012 and is headquartered in Kansas City, Kansas with an additional location in Morristown, New Jersey.

Address

1901 West 47th Place, Kansas City, KS, United States, 66205